Nkarta, Inc. (NKTX) stock
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25+0.04 (+3.31%)
Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%
Nkarta cash
Cash and short-term investments held at the end of each period.
Nkarta's cash was $182.76M at Jun 30, 2026. For fiscal 2025 it was $276.28M, up 3.3% from the year before. The highest annual figure on record is $352.14M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $276.28M | +3.3% |
| FY2024 | Dec 31, 2024 | $267.35M | +7.7% |
| FY2023 | Dec 31, 2023 | $248.19M | -29.5% |
| FY2022 | Dec 31, 2022 | $352.14M | +47.9% |
| FY2021 | Dec 31, 2021 | $238.09M | -24.4% |
| FY2020 | Dec 31, 2020 | $314.91M | +751.3% |
| FY2019 | Dec 31, 2019 | $36.99M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $182.76M | -36.9% |
| Q1 FY2026 | Mar 31, 2026 | $230.43M | -13.2% |
| Q4 FY2025 | Dec 31, 2025 | $276.28M | +3.3% |
| Q3 FY2025 | Sep 30, 2025 | $282.33M | -0.3% |
| Q2 FY2025 | Jun 30, 2025 | $289.69M | -10.8% |
| Q1 FY2025 | Mar 31, 2025 | $265.51M | -39.3% |
| Q4 FY2024 | Dec 31, 2024 | $267.35M | +7.7% |
| Q3 FY2024 | Sep 30, 2024 | $283.06M | +2.7% |
| Q2 FY2024 | Jun 30, 2024 | $324.82M | +15.7% |
| Q1 FY2024 | Mar 31, 2024 | $437.39M | +35.3% |
| Q4 FY2023 | Dec 31, 2023 | $248.19M | -29.5% |
| Q3 FY2023 | Sep 30, 2023 | $275.61M | -29.8% |
| Q2 FY2023 | Jun 30, 2023 | $280.75M | -32.0% |
| Q1 FY2023 | Mar 31, 2023 | $323.34M | +49.0% |
| Q4 FY2022 | Dec 31, 2022 | $352.14M | +47.9% |
| Q3 FY2022 | Sep 30, 2022 | $392.36M | +52.3% |
| Q2 FY2022 | Jun 30, 2022 | $412.95M | +47.6% |
| Q1 FY2022 | Mar 31, 2022 | $216.96M | -27.5% |
| Q4 FY2021 | Dec 31, 2021 | $238.09M | -24.4% |
| Q3 FY2021 | Sep 30, 2021 | $257.70M | -21.9% |
| Q2 FY2021 | Jun 30, 2021 | $279.80M | +1192.6% |
| Q1 FY2021 | Mar 31, 2021 | $299.26M | +1712.9% |
| Q4 FY2020 | Dec 31, 2020 | $314.91M | +751.3% |
| Q3 FY2020 | Sep 30, 2020 | $329.76M | +743.5% |
| Q2 FY2020 | Jun 30, 2020 | $21.65M | +266.0% |
| Q1 FY2020 | Mar 31, 2020 | $16.51M | – |
| Q4 FY2019 | Dec 31, 2019 | $36.99M | – |
| Q3 FY2019 | Sep 30, 2019 | $39.10M | – |
| Q2 FY2019 | Jun 30, 2019 | $5.91M | – |
See a number that looks wrong?